[{"address1": "4000 Shoreline Court", "address2": "Suite 300", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 822 5600", "website": "https://www.kezarlifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. It is also developing KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher J. Kirk Ph.D.", "age": 52, "title": "Co-Founder, CEO & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 927300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Franklin Fowler", "age": 52, "title": "Co-Founder & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 57037, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc L. Belsky CPA", "age": 69, "title": "CFO & Secretary", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 653208, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Schiller", "age": 44, "title": "Chief Operations Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 637985, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack  Taunton Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pattie  Chiang", "age": 62, "title": "Principal Accounting Officer, Senior VP & Corporate Controller", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joe  Tedrick", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neel K. Anand Ph.D.", "title": "Senior Vice President of Research & Drug Discovery", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Zung  To", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rachel  Peterson FACR, M.D.", "title": "Head of Clinical Immunology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.2, "open": 6.19, "dayLow": 6.05, "dayHigh": 6.29, "regularMarketPreviousClose": 6.2, "regularMarketOpen": 6.19, "regularMarketDayLow": 6.05, "regularMarketDayHigh": 6.29, "payoutRatio": 0.0, "beta": 0.507, "forwardPE": -0.5921681, "volume": 26013, "regularMarketVolume": 26013, "averageVolume": 179862, "averageVolume10days": 43460, "averageDailyVolume10Day": 43460, "bid": 4.49, "ask": 7.92, "bidSize": 2, "askSize": 2, "marketCap": 45403564, "fiftyTwoWeekLow": 3.53, "fiftyTwoWeekHigh": 7.6, "allTimeHigh": 363.3, "allTimeLow": 3.53, "fiftyDayAverage": 5.2546, "twoHundredDayAverage": 4.7433, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -34900432, "profitMargins": 0.0, "floatShares": 4725413, "sharesOutstanding": 7323156, "sharesShort": 217192, "sharesShortPriorMonth": 764048, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.0297, "heldPercentInsiders": 0.10569999, "heldPercentInstitutions": 0.57452, "shortRatio": 0.67, "shortPercentOfFloat": 0.030299999, "impliedSharesOutstanding": 7323156, "bookValue": 11.331, "priceToBook": 0.5471715, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -61705000, "trailingEps": -8.44, "forwardEps": -10.47, "lastSplitFactor": "1:10", "lastSplitDate": 1730246400, "enterpriseToEbitda": 0.541, "52WeekChange": -0.16329283, "SandP52WeekChange": 0.1265819, "quoteType": "EQUITY", "currentPrice": 6.2, "targetHighPrice": 7.0, "targetLowPrice": 5.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 90216000, "totalCashPerShare": 12.319, "ebitda": -64521000, "totalDebt": 9912000, "quickRatio": 6.894, "currentRatio": 7.065, "debtToEquity": 11.946, "returnOnAssets": -0.31273, "returnOnEquity": -0.56864, "grossProfits": -44707000, "freeCashflow": -34606752, "operatingCashflow": -56640000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "KZR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "earningsTimestamp": 1762981200, "earningsTimestampStart": 1762981200, "earningsTimestampEnd": 1762981200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -8.44, "epsForward": -10.47, "epsCurrentYear": -6.705, "priceEpsCurrentYear": -0.92468303, "fiftyDayAverageChange": 0.94539976, "fiftyDayAverageChangePercent": 0.1799185, "twoHundredDayAverageChange": 1.4566998, "twoHundredDayAverageChangePercent": 0.30710682, "corporateActions": [], "regularMarketTime": 1764363600, "exchange": "NCM", "shortName": "Kezar Life Sciences, Inc.", "longName": "Kezar Life Sciences, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "regularMarketChange": 0.0, "regularMarketDayRange": "6.05 - 6.29", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 179862, "fiftyTwoWeekLowChange": 2.6699998, "fiftyTwoWeekLowChangePercent": 0.7563739, "fiftyTwoWeekRange": "3.53 - 7.6", "fiftyTwoWeekHighChange": -1.4000001, "fiftyTwoWeekHighChangePercent": -0.18421054, "fiftyTwoWeekChangePercent": -16.329283, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "CLOSED", "messageBoardId": "finmb_304157325", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 6.2, "displayName": "Kezar Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-11-29"}]